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ABSTRACT: Canine Parvovirus enteritis is one of the most common causes of diarrhea and death in dogs younger 
than 6 months of age. Clinical gastroenteritis in parvo-positive dogs is associated with increased levels of lipid per-
oxides and alteration in antioxidant enzymes. Paraoxonase/arylesterase 1 is considered as an antioxidant enzyme and 
acute phase protein in laboratory animals and human. The present study evaluated paraoxonase activity in 27 dogs 
suffering from Parvovirus infection and compared with 9 normal dogs. Blood samples were taken from all of the dogs 
and were sent to the laboratory for complete cell blood count and also biochemical factors assessment (paraoxonase/
arylesterase 1 activity, liver, kidney and metabolic profiles). Infected dogs significantly showed decrease in paraoxo-
nase/arylesterase 1 enzyme activity, an increase number of neutrophils and lymphopenia compared with parvo-nega-
tive dogs. Significant decrease in the enzyme activity was also observed in dogs with neutropenia or leukocytosis when 
compared to control group. It seems that in dogs paraoxonase/arylesterase 1 enzyme activity is decreased as a part of 
acute phase response in Parvovirus infection. 
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INTRODUCTION 
Canine Parvovirus infection (CPV) is one of the major causes of morbidity and mortality in pup-
pies and young dogs for more than three decades (Ap-
pel et al., 1979; Decaro and Buonavoglia, 2012; de 
Oliveira et al., 2019). High mitotic rate tissues such as 
thymic cortex and germinal epithelium of the intesti-
nal crypts are the excellent targets for Parvovirus to 
lead lymphocytolysis, lymphopaenia, and collapse in 
the absorptive capacity of enterocytes (Greene, 2012). 
Clinicopathological biomarkers in this disease such 
as haematology or serum biochemistry and endo-
crine changes guide clinicians making right decision 
and help predicting outcomes (Goddard et al., 2008; 
Dossin et al., 2011; McClure et al., 2013). Recently, 
new renal biomarkers such as urinary immunoglobu-
lin G (uIgG), C-reactive protein (uCRP), neutrophil 
gelatinase associated lipocalin (uNGAL) and urinary 
protein/ creatinine ratio (UPC) have been detected in 
parvo infected dogs suffering from acute kidney in-
jury (Van den Berg et al., 2018). Serum paraoxonase 
or (PON1) (aryldialkylphosphatase, EC 3.1.8.1) is an 
antioxidant enzyme belonging to hydrolase family 
which is synthesized by the liver and causes degra-
dation of lipid oxidation products and lactones such 
as homocysteine thiolactone (Rosenblat et al., 2006; 
Weijun et al., 2008; Altenhöfer et al., 2010; Ciftci et 
al., 2015). Alteration in level of PON1 had been ap-
proved in various diseases involving inflammation 
and oxidative stress such as cardiovascular, renal and 
liver diseases or obesity (Camps et al., 2007; Ferret-
ti et al., 2010; Zhao et al., 2012; Zhang et al., 2015; 
Dalal et al., 2018). For these properties, this enzyme 
attracted scientists’ attention in human and veterinary 
medicine as a novel biomarker of oxidative stress 
or acute phase response (Rossi et al., 2013; 2014a,b; 
Tvarijonaviciute et al., 2015; Moya and Manez, 
2018). The current study was conducted to evaluate 




This retrospective study performed on 27 Par-
vovirus infected dogs (test group) and 9 healthy dogs 
(control group) that were admitted to the Hospital of 
Veterinary School of Shahid Bahonar University of 
Kerman in Iran for treatment and routine check-ups 
respectively. Animals were client-owned dogs aged 
between 2- to14-month-old from both genders and 
mixed breed. 
Animal ethics
The study was conducted in accordance to the 
guidelines for use of animals in research and approved 
by the State Committee on Animal Ethics, School of 
Veterinary Medicine, Shahid Bahonar University of 
Kerman, Kerman, Iran. 
Blood samples
Blood samples were taken from cephalic vein 
(2.5 ml) and were divided into two parts. 0.5 ml of 
the blood sample was anticoagulated with EDTA for 
complete cell blood count (CBC) analysis and 1.5 ml 
of the blood sample was centrifuged at 750 g for 15 
min in order to separate sera for measuring PON1 ac-
tivity, liver, kidney and metabolic profiles. 
Complete blood count parameters 
Immediately after blood collection, samples with 
EDTA were used to prepare blood smear for measur-
ing white blood cell (WBC), red blood cell (RBC) 
count and hematocrit. 
Serum biochemical analysis
The sera were analyzed for total protein (Biuret 
method), albumin (Bromocresol green), alkaline 
phosphatase enzyme activity (ALP), blood urea nitro-
gen or BUN (Urease method), creatinine (Jaffe meth-
od), cholesterol, high density lipoprotein (HDL), low 
density lipoprotein (LDL) and triglyceride (TG) us-
ing commercial kits (Pars Azmoon Co., Tehran, Iran). 
Alanine aminotransferase (ALT) and aspartate ami-
notransferase (AST) activities were measured using 
Reitman and Frankel colorimetric method (Reitman 
and Frankel, 1957). Analysis procedure was carried 
out using automated analyzer (Ames, Rome, Italy). 
PON1 enzymatic activity was assessed using com-
mercial kit (ZellBio GmbH, Germany) according to 
manufacturer instruction briefly by measuring in vi-
tro hydrolysis of paraoxon to ρ-nitrophenol. Product 
absorbance measurement (412 nm) was carried out 
using microplate spectrophotometer (Epoc, BioTek 
Instruments Inc., USA). Based on the results of the 
study by Rossi and her colleagues, paraoxon- based 
methods were accurate and precise for evaluating the 
esterase activity of PON1 in canine serum (Rossi et 
al., 2013). 
Statistical Analysis
Statistical analysis was performed using the SPSS 
software® (Version 17 for Windows; SPSS Inc., Chi-
cago, IL, USA). Data was checked for normal dis-
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tribution using the Kolmogorov-Smirnov test. Com-
parison of mean values within groups was performed 
using Independent Samples T-Test. P value less than 
0.05 was considered statistically significant. Potential 
correlation between PON1 and other parameters was 
determined using the Pearson Correlation test.
RESULTS 
In this study, blood samples selected from healthy 
dogs and dogs suffering from Parvovirus infection. 
A complete evaluation of the history, physical ex-
amination findings, hematology and biochemical 
analysis were performed on all animals. Parvovirus 
infection was admitted by both clinical examination 
and a point-of-care test (ICT test, Quicking Biothech 
Co., Ltd, China). In order to prevent misdiagnosing 
Parvovirus infection, we excluded dogs that had been 
vaccinated two weeks earlier. Anorexia, vomiting and 
diarrhea were reported in the history of the dogs in 
the test group. Healthy dogs (n=9) were presented 
to clinic for routine check-ups. They did not present 
any clinical evidence of disease and absence of CPV 
was confirmed by a point-of-care test. Blood samples 
were taken within 2 hours of admission before any 
treatment. Data were presented as means ± standard 
errors (X ± SE) in Tables (1, 2) and Figures (1-5). 
As shown in Table 1, significant differences were ob-
served in lymphocyte, segmented and band neutrophil 
between healthy and infected dogs. There was signifi-
cant difference in PON1 activity between healthy and 
parvo-positive dogs (Fig 1); however, there was no 
significant difference in PON1 activity between in-
fected dogs without neutropenia in comparison with 
neutropenic dogs (Fig 2). In Fig 3, lower PON1 activ-
ity also was seen in neutropenic dogs in comparison 
with healthy ones (P=0.03). There was no significant 
difference in PON1 activity between infected dogs 
without cytosis in comparison with dogs which had 
cytosis; in contrast, there was significant decrease in 
PON1 activity in dogs that had cytosis compared with 
healthy dogs (P=0.02) (Fig 4, 5). According to the re-
sults in Table 2, significant differences were observed 
in creatinine, albumin, total protein concentrations 
and ALT activity between two groups. There were no 
significant differences between triacylglycerol (TG), 
high density lipoprotein (HDL), low density lipopro-
tein (LDL) and cholesterol between groups.
Table 1. The Mean ± SE of blood components in healthy and infected dogs




Segmented neutrophil 4.78±1.47 10.37±13.50*




*Asterisk showed significant differences between groups (P<0.05).
Table 2. The concentration of biochemical factors (Mean ± SE) in healthy and infected dogs
Parameters Healthy dogs Infected dogs
AST (U/ml) 40.33±21.27 72.44±86.61
ALT (U/ml) 29.33±13.72 82.70±110.26*
ALP (U/ml) 436.67±320.28 492.37±466.46
BUN (mmol/L) 21.84±17.50 28.31±18.02
Creatinine (µmol/L) 102.54±19.44 79.56±32.70*
TG (mmol/L) 0.90±0.26 1.02±0.40
Cholesterol (mmol/L) 5.91±0.37 3.61±1.56
HDL(mmol/L) 2.85±0.70 3.12±0.92
LDL (mmol/L) 1.55±0.84 2.20±1.45
Albumin (g/L) 36.2±3.7 30.1±6.9*
Total protein (g/L) 720±63.6 711±168.8*
*Asterisk showed significant differences between groups (P<0.05).
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Fig 1. The activity of PON1 (U/ml) in healthy (1) and infected 
dogs (2)
*Asterisk showed significant differences between groups 
(P<0.05).
Fig 2. The activity of PON1 (U/ml) in dogs without neutropenia 
(1) in comparison with infected neutropenic dogs (2)
 
Fig 3. The activity of PON1 (U/ml) in healthy dogs (1) in compar-
ison with neutropenic infected dogs (2)
*Asterisk showed significant differences between groups 
(P=0.03).
 
Fig 4. The activity of PON1 (U/ml) in infected dogs without cyto-
sis (1) in comparison with infected dogs with cytosis (2)
 
Fig 5. The activity of PON1 (U/ml) in healthy dogs (1) in compar-
ison with infected dogs with cytosis (2)
*Asterisk showed significant differences between groups 
(P=0.02).
DISCUSSION
Findings of this study demonstrated that all of the 
Parvovirus infected dogs had lower PON1 activity 
compared with healthy ones. It seemed that PON1 en-
zyme was deactivated in the course of the Parvovirus 
infection as an acute phase response. Canine Parvovi-
rus enteritis is an acute gastrointestinal illness that 
is seen mostly in puppies and young dogs. Since it’s 
emerging in 1979, numerous scientific efforts were 
established in order to find reliable clinicopathologi-
cal biomarkers for this contagious disease (Schoeman 
et al., 2013; Hoang et al., 2019). Some researches re-
vealed that inflammation state and alteration in profile 
of serum acute-phase proteins occurred in the time of 
the canine Parvovirus infection; therefore, the anti-in-
flammatory body’s reaction would be as reflex of dis-
ease severity (Kocaturk et al., 2010, McClure et al., 
2013). PON1 is tightly associated with apolipoprotein 
A1 in HDL and exerts its protective function through 
hydrolyzing oxidized lipids (Aviram et al., 2000). 
During an acute phase response, HDL molecules lose 
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its associated enzymes, including PON1, which is re-
placed by serum amyloid A and ceruloplasmin. This 
phenomenon results in reduced antioxidative proper-
ties of HDL (Cabana et al., 2003; Novak et al., 2010). 
Alteration in serum PON1 had been correlated with 
inflammation and oxidative damage in many clinical 
conditions (Rosenblat et al., 2006; Zhao et al., 2012; 
Tecles et al., 2015; Arenas et al., 2018). The main goal 
of this experiment was attempting to find whether or 
not level of PON1 activity would have been changed 
in dogs that were infected with the Parvovirus enteri-
tis. As noted in the results, the significant decrease in 
PON1 activity was observed in dogs suffering from 
Parvovirus enteritis when it was compared with 
healthy dogs (Fig 1). This phenomenon probably ex-
hibited that low PON1 activity was linked to a part 
of acute phase response in the course of the Parvovi-
rus infection. This was approved by Rossi and her 
coworkers (2014a) who revealed that PON1 activity 
was decreased in dogs that were affected by leishman-
iasis. After medication of leishmaniasis, normalized 
PON1 activity was seen earlier than other inflamma-
tory biomarkers in cases with systemic inflammation 
(Rossi et al., 2014a). These researchers concluded that 
low value of PON1 activity might indicate sever in-
flammation during leishmaniasis (Rossi et al., 2014a). 
Other investigation also suggested the relationship 
between reduction in serum PON1 activity and stern-
ness of infection in dogs with acute pancreatitis (Tvar-
ijonaviciute et al., 2015). Sensitivity of PON1 activity 
to inflammatory conditions and oxidative stress was 
approved in other small animals by Tecles and his col-
leagues in 2015. These researchers established that in 
cats with infectious peritonitis (FIP) not only PON1 
level was considerably decreased but total antiox-
idant capacity was diminished (Tecles et al., 2015). 
Findings in Table 1 showed that, both segmented and 
band neutrophil were increased (probably because 
of secondary infections) and lymphocyte number 
was decreased noticeably in infected dogs compared 
with parvo-negative cases. Lower PON1 activity was 
seen in neutropenic infected dogs in comparison with 
healthy group (P=0.03) (Fig 3). There was significant 
decrease in PON1 activity in infected dogs that had 
cytosis compared with healthy dogs (P=0.02) (Fig 
5). This result proposed the relationship between low 
PON1 activity and severity of the CPV in dogs. PON1 
is an antioxidant enzyme so antioxidant capacity of 
infected dogs is decreased with lowered PON1 activ-
ity. This is in agreement with an investigation which 
was done by Panda and coworkers in (2009) which 
revealed that clinical gastroenteritis in parvo-positive 
dogs was associated with increased levels of lipid per-
oxides and alteration in antioxidant enzymes in the 
erythrocytes (Panda et al., 2009). PON1 is a glycopro-
tein that associated with HDL in circulating system so 
it was expected that level of HDL would have been 
declined if PON1 activity was reduced. Surprisingly 
as shown in Table 2, there were no significant differ-
ences in HDL and other metabolic parameters like 
TG, LDL and cholesterol between groups. This was in 
conflict with previous study which had shown that se-
rum total cholesterol and HDL levels were decreased 
and TG level was increased in dogs with Parvovirus 
enteritis (Yilmaz and Senturk, 2007). This study per-
formed on a limited number of samples, however; 
a large population of dogs with naturally occurring 
Parvovirus infection could lead to a higher general-
ization of our results.
CONCLUSIONS
It was found that all of the infected dogs and also 
cases with neutropenia or cytosis had lower PON1 
activity compared with parvo-negative cases; there-
fore, it seemed that PON1 activity level in serum is 
sensitive to Parvovirus infection. This investigation 
emphasized possible contribution of PON1 level as an 
antioxidant enzyme and negative acute phase reactant 
in canine Parvovirus infection.
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